Proprietary technology utilized in Market-Leading Device Now Cleared for Sale
BEMER International today announces the upcoming availability and national product launch of BEMER Pulsed Electromagnetic Field (PEMF) technology across Canada. BEMER has developed patented PEMF technology globally for more than 20 years in order to improve blood circulation. Now, BEMER products will be available to doctors, health professionals, and individuals for home use throughout Canada on April 15, 2019.
Health Canada cleared BEMER devices with a Class 2 medical device license. The innovative technology used by BEMER makes them unique in the PEMF market. BEMER’s patented technology has been used for decades by doctors, chiropractors, sports medicine and wellness advocates globally.
“We have made BEMER technology available all over the world for the last 20 years, always with the goal of someday introducing it across Canada,” said Nick Huish, General Manager, BEMER North America. “We are thrilled that Canada will now have the opportunity to use the BEMER technology in order to improve their health, well-being and quality of life”.
BEMER technology is a pulse that stimulates microcirculation which improves overall blood flow. Improved circulation has a large range of positive benefits; blood flow removes toxins, increases transportation of oxygen and delivery of nutrients throughout the body. The unsurpassed BEMER-Signal sets a new standard in the industry with its complex, carefully tuned configuration and timing. Nearly two decades of research and development have resulted in very specific and highly effective modulations of amplitude and frequency, which is a feat of engineering used exclusively by BEMER.
While PEMF technology is widely available through a variety of devices, any positive effects rest squarely with the radio frequency being applied to the body (inductive effect). BEMER researched and patented its own waveform while refining the application device to achieve a superior technology and market the best PEMF products on the market today. The unique BEMER signal is generated in the control unit and then transmitted to the application modules for delivery throughout the body.
“People can do a lot to improve their health and wellness through managing one’s lifestyle. Making BEMER a part of a Therapeutic Lifestyle Change (TLC) supports the body’s circulatory system and is an act of preventative care. Regular use of BEMER has shown to increase overall health and quality of life,” said Dr. Joshua Berka, NMD. “The BEMER medical device has been researched and perfected over the years and is a therapeutic modality that I am confident to recommend to my patients. It is a safe and effective product that people can be deployed clinically or used in a home care environment.”
BEMER is available exclusively through direct sales with a BEMER distributor. For information go to: https://life.bemergroup.com/
BEMER® USA is a subsidiary of BEMER International AG, a leading global medical device company specializing in the research and development of microcirculation products. Founded in 1998, BEMER now operates in over 42 countries, with hundreds of employees and thousands of independent distributors. BEMER is a leading innovator in physical vascular therapy technology and holds an FDA registration along with numerous technology patents, as well as a joint collaboration agreement with NASA. BEMER products have been shown to increase blood circulation, which can enhance Cardiac Function, Muscle Stimulation, Muscle Recovery, Physical Fitness/Endurance, Stress Reduction, Relaxation and Sleep Quality. BEMER products are currently used globally by millions of consumers, hospitals and clinics, as well as hundreds of professional athletes.
Tim Sullivan Lynette Pettinicchi